<DOC>
	<DOCNO>NCT03067285</DOCNO>
	<brief_summary>A phase IV , multicentre , randomise , open-label , pilot clinical trial design evaluate HIV-infected , aviremic patient receive treatment combination DTG/3TC/ABC neuropsychiatric adverse effect , opinion investigator , may relate take DTG/3TC/ABC , improve switch antiretroviral therapy combination ELV/COBI/FTC/TAF .</brief_summary>
	<brief_title>A Phase IV , Open-label , Randomised , Pilot Clinical Trial Designed Evaluate Potential Neurotoxicity Dolutegravir/Lamivudine/Abacavir Neurosymptomatic HIV Patients Its Reversibility After Switching Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide . DREAM Study</brief_title>
	<detailed_description>estimate 64 participant need enrol study demonstrate symptomatic improvement switch antiretroviral therapy DTG/3TC/ABC ELV/COBI/FTC/TAF .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Dolutegravir</mesh_term>
	<criteria>Patient &gt; 18 year age diagnose HIV use normal serology technique . Current antiretroviral therapy DTG/3TC/ABC . HIV viral load &lt; 50 copies/mL least 12 week prior sign consent form [ ( ] confirm two assay least 12 week apart viremia &lt; 50 copies/mL ) . If patient recent routine blood test available ( ≤ 4 week ) include determine HIV viral load , result may use screen visit . If test available , test four week old , viral load determine day screen order confirm patient meet criterion . Appearance worsen follow symptom compare DTG/3TC/ABC start : Symptoms anxiety depression Insomnia sleep disturbance Headache Cognitive complaint ( attention , concentration memory ) Alterations behaviour ( irritability , aggressiveness agitation ) Dizziness neurological neurologicallymediated origin Determination least one HIV viral load ≥ 50 copies/mL last 12 week . Allergy , intolerance existence resistance mutation component ELV/COBI/FTC/TAF History active CNS infection Active psychosis , major depression psychotic symptom autolytic ideation Dementia mental retardation Drug use diagnosis abuse dependence accord DSM5 criterion Illnesses may interfere study procedure Claustrophobia Presence magnetisable device body Inability complete study procedure Pregnant nursing woman , well woman childbearing age agree use adequate birth control method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>